Lycia Therapeutics
Ming is a Managing Director at Redmile Group, LLC, a healthcare-focused investment firm. Prior to joining Redmile in 2016, Ming worked in the healthcare space as an investor at Safeguard Scientifics, a consultant at McKinsey & Company and ZS Associates, and an operator at Gilead Sciences. Ming graduated with a B.A. in Computer Science from UC Berkeley and an MBA in Finance and Healthcare Management from the Wharton School of Business.
This person is not in the org chart
This person is not in any offices
Lycia Therapeutics
1 followers
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.